These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35150325)

  • 1. Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress.
    Kaur E; Ketkar M; Dutt S
    Med Oncol; 2022 Feb; 39(5):50. PubMed ID: 35150325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells.
    Ahmed SU; Carruthers R; Gilmour L; Yildirim S; Watts C; Chalmers AJ
    Cancer Res; 2015 Oct; 75(20):4416-28. PubMed ID: 26282173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase.
    Carruthers R; Ahmed SU; Strathdee K; Gomez-Roman N; Amoah-Buahin E; Watts C; Chalmers AJ
    Mol Oncol; 2015 Jan; 9(1):192-203. PubMed ID: 25205037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.
    Saha J; Wang M; Cucinotta FA
    DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells.
    Carruthers RD; Ahmed SU; Ramachandran S; Strathdee K; Kurian KM; Hedley A; Gomez-Roman N; Kalna G; Neilson M; Gilmour L; Stevenson KH; Hammond EM; Chalmers AJ
    Cancer Res; 2018 Sep; 78(17):5060-5071. PubMed ID: 29976574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Eich M; Roos WP; Nikolova T; Kaina B
    Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma.
    Ferri A; Stagni V; Barilà D
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
    Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
    Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
    Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
    Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of ataxia telangiectasia mutated kinase inhibitors.
    Andrs M; Korabecny J; Nepovimova E; Jun D; Hodny Z; Moravcova S; Hanzlikova H; Kuca K
    Mini Rev Med Chem; 2014; 14(10):805-11. PubMed ID: 25138084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.
    Middleton FK; Patterson MJ; Elstob CJ; Fordham S; Herriott A; Wade MA; McCormick A; Edmondson R; May FE; Allan JM; Pollard JR; Curtin NJ
    Oncotarget; 2015 Oct; 6(32):32396-409. PubMed ID: 26486089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
    Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
    Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM and ATR as therapeutic targets in cancer.
    Weber AM; Ryan AJ
    Pharmacol Ther; 2015 May; 149():124-38. PubMed ID: 25512053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture.
    Tribius S; Pidel A; Casper D
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):511-23. PubMed ID: 11380241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM inhibition prevents interleukin-6 from contributing to the proliferation of glioblastoma cells after ionizing radiation.
    Lim YC; Quek H; Offenhäuser C; Fazry S; Boyd A; Lavin M; Roberts T; Day B
    J Neurooncol; 2018 Jul; 138(3):509-518. PubMed ID: 29564746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DUSP6 regulates radiosensitivity in glioblastoma by modulating the recruitment of phosphorylated DNAPKcs at DNA double-strand breaks.
    Nair J; Basha Syed S; Mahaddalkar T; Ketkar M; Thorat R; Sastri Goda J; Dutt S
    J Cell Sci; 2021 Dec; 134(24):. PubMed ID: 34792128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence.
    Kaur E; Rajendra J; Jadhav S; Shridhar E; Goda JS; Moiyadi A; Dutt S
    Carcinogenesis; 2015 Jun; 36(6):685-95. PubMed ID: 25863126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - a short report.
    Kaur E; Goda JS; Ghorai A; Salunkhe S; Shetty P; Moiyadi AV; Sridhar E; Mahajan A; Jalali R; Dutt S
    Cell Oncol (Dordr); 2019 Feb; 42(1):107-116. PubMed ID: 30361826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
    Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
    Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.